RecruitingNCT06235619

Arch Size Study for Anatomical Variations

CT Anatomical Characteristics of the Aortic Arch in Subjects With or Without Aneurysms Requiring Treatment


Sponsor

IRCCS San Raffaele

Enrollment

500 participants

Start Date

Sep 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aortic arch with a common origin of the innominate and left carotid artery (CILCA) prevalence in the general population is 13.6%. Its reputation as a benign anatomical variant has been ultimately shattered by further studies that identified the CILCA arch as a potential marker for thoracic aortic disease (TAD) The aim of this work is to report the CT anatomical characteristics of the aortic arch in subjects with or without aneurysms requiring treatment, in 5 major European cardiovascular centers.


Eligibility

Min Age: 0 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with aneurysm, aortic arch, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 0 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IRCCS San Raffaele Hospital

Milan, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06235619


Related Trials